Lakewood-Amedex Biotherapeutics, Inc. (LABT)
2.22
+0.17
(+8.29%)
USD |
NASDAQ |
Sep 11, 16:00
2.15
-0.07
(-3.15%)
Pre-Market: 09:08
Lakewood-Amedex Biotherapeutics Shareholders Equity (Quarterly) : 4.331M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.331M |
| March 31, 2026 | -2.842M |
| December 31, 2025 | -1.964M |
| September 30, 2025 | -1.266M |
| Date | Value |
|---|---|
| June 30, 2025 | -0.6833M |
| March 31, 2025 | -0.0762M |
| December 31, 2024 | 0.4096M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.96M |
| Total Liabilities (Quarterly) | 0.6289M |
| Debt to Equity Ratio | 0.0235 |
| Current Ratio | 7.704 |
| Net Debt Paydown Yield | 1.01% |